Publication | Closed Access

A diphtheria toxin interleukin-3 fusion protein synergizes with tyrosine kinase inhibitors in killing leukemic progenitors from BCR/ABL positive acute leukemia

Hematological MalignancyLeukemic ProgenitorsMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyCell DeathImmune Checkpoint InhibitorTyrosine Kinase InhibitorsAdult T-cell Leukemia-lymphomaImmunotherapyMedicineCell BiologyCell SignalingTumor Biology